Clinical Trial Update: Transplantation of Ex-vivo Expanded Cord Blood Stems Cells [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transplantation of ex-vivo expanded cord blood stem cells for malignant hematologic diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Cord blood stem cells (ex-vivo expanded)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Malignant Haematological Disease | Phase 2 | Status: COMPLETED